SCHEMBL17818666

SCHEMBL17818666

O=C(O)C(C(=O)O)C(=O)O.[Ag]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
TSHR P16473 1/20 0.43
THRB P10828 1/20 0.43
RECQL P46063 1/20 0.43
TDP1 Q9NUW8 3/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
ABCB11 O95342 1/20 0.40
F2 P00734 1/20 0.40
TP53 P04637 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP2C19 P33261 1/20 0.40
DUSP3 P51452 1/20 0.40
PTPN5 P54829 1/20 0.40
PTPN11 Q06124 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL445370 0.95 ALDH1A1 (0.46) ALDH1A1LMNATSHRTHRBRECQL
SCHEMBL27535153 0.90 ALDH1A1 (0.43) ALDH1A1LMNATSHRTHRBRECQL
Trimethylammonium SCHEMBL27969111 0.79 TP53 (0.41) ALDH1A1LMNATSHRTHRBRECQL
Ethylamine SCHEMBL11870442 0.73 GABRR1 (0.43) TDP1TP53OR51E2
SCHEMBL7852465 0.73 CA1 (0.42) ALDH1A1LMNATSHRTHRBRECQL
SCHEMBL8828681 0.70 ACHE (0.43) ALDH1A1LMNATSHRTHRBRECQL
SCHEMBL2727249 0.70 ACHE (0.43) ALDH1A1LMNATSHRTHRBRECQL
SCHEMBL3621120 0.70 FFAR3 (0.43) ALDH1A1LMNATSHRTHRBRECQL
SCHEMBL28523 0.70 FFAR3 (0.43) ALDH1A1LMNATSHRTHRBRECQL
SCHEMBL26629782 0.70 ALDH1A1 (0.35) ALDH1A1LMNATSHRTHRBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9683123-B2 Silver ink PESOLVE CO., LTD. (KR) 2017-06-20 US disclosed
US-20160168408-A1 SILVER INK PESOLVE CO., LTD. (KR) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168408-A1 SILVER INK TP53, MKI67, NRAS ALDH1A1 23/4885LMNA 4641/4885TSHR 4766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.